Retraction Note: miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3

F.-J. Meng, F.-M. Meng, H.-X. Wu, X.-F. Cao

Laboratory Medicine, Yidu Central Hospital of Weifang City, Weifang, Shandong, China

---

• Oncology

The article “miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3” by F.-J. Meng, F.-M. Meng, H.-X. Wu, X.-F. Cao published in Eur Rev Med Pharmacol Sci 2017; 21 (21): 4828-4834–PMID: 29164580 has been retracted in accordance with the authors, the Publisher, and the Editor in Chief.

The authors initially informed the journal of their intention to retract the article due to data inaccuracies and a lack of clarity in some figures.

The journal’s investigation additionally identified image duplications within the cell migration and invasion assay panels (panels G and H of Figure 3), as well as among the Western blot images (panels E and F of Figure 3).

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3

Free PDF Download